The haemodynamic effect of superficial cervical plexus blockade in patients undergoing carotid endarterectomy under general anaesthesia

ISRCTN ISRCTN52716583
DOI https://doi.org/10.1186/ISRCTN52716583
Secondary identifying numbers N/A
Submission date
02/11/2005
Registration date
28/11/2005
Last edited
26/05/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Gerard Danjoux
Scientific

Anaesthetic Department
Cheriton House
James Cook University Hospital
Marton Road
Middlesbrough
TS4 3BW
United Kingdom

Phone +44 (0)1642 850850 ext 4600
Email gerard.danjoux@stees.nhs.uk

Study information

Study designRandomised controlled double blind trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesCarotid endarterectomy is performed in patients with severe stenosis (narrowing) of the carotid arteries. The operation improves blood supply to the brain and reduces the risk of stroke in selected patients. In the early post operative period following carotid endarterectomy patients commonly develop blood pressure lability. It is our observation that severe hypertension has decreased whilst hypotension requiring treatment has increased in our patient group over the past 2 years. Two changes in our practise may be contributing to this - first the majority of patients are now beta blocked, secondly our patients are now commonly given a superficial cervical plexus block. We aim to establish the influence of superficial cervical plexus blockade on post operative blood pressure control in these patients.

Our null hypothesis is that there is no clinically significant difference in the mean blood pressures in the first 24 hours following carotid endarterectomy in patients who have been given a superficial cervical plexus block and those who have not.
Ethics approval(s)Ethics approval received on the 22nd July 2004; amendment approved 27th May 2005 (ref: 04/Q1001/21).
Health condition(s) or problem(s) studiedBlood pressure lability
InterventionPatients will receive a superfical cervical plexus block with either 2 mg/kg of laevo-bupivacaine or a placebo block with the equivalent volume of saline
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Laevo-bupivacaine
Primary outcome measureMean systolic blood pressures over the first 24 hours postoperatively.
Secondary outcome measures1. Need for antihypertensive treatment
2. Need for pressor treatment
3. Cumulative dose of any vasoactive medication
4. Mean pain scores
5. Cumulative opiate requirements

Any cardiovascular, cerebrovascular or other major morbidity or mortality occuring during the time period and any complication potentially related to the superficial cervical plexus block will also be recorded.
Overall study start date20/11/2005
Completion date20/11/2006
Reason abandoned (if study stopped)Objectives no longer viable

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants54
Key inclusion criteriaPatients at James Cook University Hospital undergoing carotid endartectomy
Key exclusion criteriaPatients will be excluded if they:
1. Do not wish to take part
2. Are unfit for a general anaesthetic
3. Have a contraindication to either beta blockers or to being given a local anaesthetic block (e.g. local anaesthetic allergy and bleeding tendency)
Date of first enrolment20/11/2005
Date of final enrolment20/11/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Anaesthetic Department
Middlesbrough
TS4 3BW
United Kingdom

Sponsor information

James Cook University Hospital (UK)
Hospital/treatment centre

Cheriton House
Anaesthetic Department
Marton Road
Middlesbrough
TS4 3BW
England
United Kingdom

Phone +44 (0)1642 850850 ext 4600
Email drsarah.platt@virgin.net
ROR logo "ROR" https://ror.org/02vqh3346

Funders

Funder type

Hospital/treatment centre

James Cook University Hospital (UK) - Anaesthetic Department

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan